InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc. (IXSBF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ixsbf · pe ratio · data through Jun 30, 2010
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for InNexus Biotechnology, Inc. (IXSBF) measures how much investors pay for each dollar of the company's trailing earnings. IXSBF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.07.
Source: FMP · /ratios-ttm · /analyst-estimates · 2010-06-30
PE Ratio History
2000 – 2010 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
InNexus Biotechnology, Inc.You IXSBF | $0M | N/A | — | -$0.07 |
 Biomagnetics Diagnostics Corp. BMGP | $0M | N/A | — | -$0.00 |
 NanoLogix, Inc. NNLX | $0M | N/A | — | -$0.01 |
 ORHub, Inc. ORHB | $1M | N/A | — | -$0.02 |
 Strategic Partners A/S OZYMF | $4M | N/A | — | -$20.59 |
 PaxMedica, Inc. Common Stock PXMD | $0M | N/A | — | -$11.00 |
 SmileDirectClub, Inc. SDCCQ | $0M | N/A | — | -$0.71 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2010-06-30Latest FY2010 | — | $-0.07 | — | |
2009-06-30 FY2009 | — | $-0.11 | — | |
2008-06-30 FY2008 | — | $-0.11 | — | |
2007-06-30 FY2007 | — | $-0.12 | — | |
2006-06-30 FY2006 | — | $-0.12 | — | |
2005-06-30 FY2005 | — | $-0.10 | — | |
2004-06-30 FY2004 | — | $-0.06 | — | |
2003-06-30 FY2003 | — | $-0.06 | — | |
2002-06-30 FY2002 | — | $-0.08 | — | |
2001-06-30 FY2001 | — | $-0.08 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for InNexus Biotechnology, Inc. (IXSBF) measures how much investors pay for each dollar of the company's trailing earnings. IXSBF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.07.
Frequently asked questions
IXSBF pe ratio · 6 questionsIXSBF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.07. Data sourced from Financial Modeling Prep via IXSBF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · InNexus Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09